View Archive

Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Genentech, Inc.; Puma Biotechnology, Inc.; and Seattle Genetics Inc.

MBCC: How We Do it: Personalizing Treatment for Patients With HER2-Positive Breast Cancer

MBCC: How We Do it: Personalizing Treatment for Patients With HER2-Positive Breast Cancer

Sunday, March 8, 2020

Breakfast and Registration: 6:30 AM – 7:00 AM
Scientific Session: 7:00 AM – 8:30 AM

Fontainebleau Miami Beach

Meeting Room: Fontaine
4441 Collins Avenue
Miami Beach, FL 33140

Personalizing Treatment for Patients With HER2-Positive Breast Cancer Overview

Outcomes for patients with early stage HER2+ breast cancer have been dramatically improved by implementation of adjuvant trastuzumab. Moreover, strategies aimed at further extending survival in this setting are under investigation in trials evaluating extended therapy, dual targeting, and adjuvant treatment of patients with residual disease following neoadjuvant treatment. However, resistance to HER2 targeting remains a clinically unmet need in the field. As such, greater understanding of mechanisms of resistance to standard therapies is spurring investigation of novel pathways and targets to overcome treatment barriers for those with advanced disease.

This satellite symposium at the 37th Annual Miami Breast Cancer Conference® will aim to provide practitioners with expert guidance on how to incorporate recent trial data in the treatment of patients with both early and advanced HER2+ breast cancer, as well as how to address clinical scenarios that do not fit neatly into currently available data sets in this therapeutic space. Faculty presentations and a case-based discussion will cover topics including HER2-targeted agents in early and advanced breast cancer, emerging systemic treatment options for patients with brain metastases, pertinent ongoing clinical trial data, and supportive care strategies for mitigating the effects of adverse events associated with current treatment paradigms.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Genentech, Inc.; Puma Biotechnology, Inc.; and Seattle Genetics Inc.

Target Audience: HCPs Who Treat Breast Cancer

This activity is directed toward medical and surgical oncologists who treat patients with breast cancer. Fellows, nurses, nurse practitioners, physician assistants, pathologists, radiation oncologists, and other healthcare professionals (HCPs) involved in the management of patients with breast cancer are also invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Integrate data from recent clinical trials evaluating HER2-targeted agents into personalized treatment algorithms to optimize outcomes for patients with early stage or advanced/metastatic HER2+ breast cancer
  • Evaluate emerging systemic treatment options for patients with HER2+ breast cancer with brain metastases
  • Discuss ongoing clinical trials investigating novel approaches for HER2+ breast cancer, and their potential impact on evolving treatment paradigms for managing HER2+ breast cancer
  • Utilize supportive care strategies for preventing and/or ameliorating treatment-related adverse events in patients receiving HER2-targeted therapy for breast cancer

Program Chair

Debu Tripathy
Debu Tripathy, MD
Professor and Chair
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, TX


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

In case of onsite emergency:

Professional Information


Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19

I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventative measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, or I have been in close contact with anyone that has been diagnosed with COVID-19, then I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities.

I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.

* By checking this box, you have read and understand the above and agree to its terms.

Calendar of Events
Filter By